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Background: Nightmares and bad dreams are common in people with emotional disturbances. For example,
nightmares are a core symptom in posttraumatic stress disorder and about 50% of borderline personality disorder
patients suffer from frequent nightmares. Independent of mental disorders, nightmares are often associated with
sleep problems such as prolonged sleep latencies, poorer sleep quality, and daytime sleepiness. It has not been
well documented whether this is reflected in objectively quantifiable physiological indices of sleep quality.
Methods: Questionnaires regarding subjective sleep quality and ambulatory polysomnographic recordings of
objective sleep parameters were collected during three consecutive nights in 17 individuals with frequent
nightmares (NM) and 17 healthy control participants (HC).
Results: NM participants reported worse sleep quality, more waking problems and more severe insomnia
compared to HC group. However, sleep measures obtained by ambulatory polysomnographic recordings revealed
no group differences in (a) overall sleep architecture, (b) sleep cycle duration as well as REM density and REM
duration in each cycle and (c) sleep architecture when only nights with nightmares were analyzed.
Conclusions: Our findings support the observation that nightmares result in significant impairment which is
independent from disturbed sleep architecture. Thus, these specific problems require specific attention and
appropriate treatment.
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Nightmares are commonly defined as disturbing dreams
characterized by awakening from (REM) sleep with very
vivid and detailed dream recall. Dream content is typic-
ally related to threats to survival, security or self-esteem
[1,2]. For the diagnosis of nightmare disorder, dream
content and the awakening must cause clinically signifi-
cant distress or impairment in important areas of func-
tioning [2,3]. At least one nightmare per week is often
used as criterion as this frequency seems to cause clinic-
ally significant distress [4]. Nightmares are associated with
disturbed sleep, low well-being and affect daytime mood
and behavior. Nightmare disorder is a very common* Correspondence: franc.paul@zi-mannheim.de
1Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg
University, J5, Mannheim 68159, Germany
Full list of author information is available at the end of the article
© 2015 Paul et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.comorbidity in nearly all psychiatric conditions. In border-
line personality disorder (BPD), for example, up to 50%
are troubled by frequent nightmares [5–7]. Correspond-
ingly, BPD can be found in nearly one quarter of people
who suffer from nightmares [8]. Moreover, nightmares are
also a core symptom in posttraumatic stress disorder
(PTSD) with about two thirds of patients suffering from
terrifying dreams [9].
Anxiety or fear are often reported as the predominant
emotions of nightmares, but recent research suggests
that other, less intense emotions like frustration or guilt
can be involved as well [10]. The prevalence of frequent
nightmares in the general population is about 5% in
adults [11–13] and even higher in childhood and adoles-
cence [14–18].
To compare results of different studies, it is important
to define nightmares and distinguish them from otheris is an Open Access article distributed under the terms of the Creative
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mares are very unpleasant and disturbing dreams which
awaken the dreamer [3,10], compared to other unpleas-
ant and disturbing dreams that do not awaken a person
[10]. The distinction is also important because results
indicate that there is a stronger relationship between
impaired well-being and nightmare frequency than bad
dream frequency [19]. Furthermore, the same study found
that people with frequent nightmares also reported to
have frequent bad dreams, whereas those with a high
frequency of bad dreams did not experience frequent
nightmares [19].
People who frequently experience nightmares often
report massively reduced sleep quality. Nightmare suf-
ferers (between 10–16 nightmares on average per month)
scored worse on self-report measures; they fear going to
sleep, experience awakenings from sleep, have difficulty
falling asleep again and have fitful sleep patterns [20].
About 50-60% with much less frequent nightmares (2.7 ±
3.3 in the last month) also reported difficulties to fall
asleep again and described their post nightmare sleep as
more restless and uncomfortable as well as less refreshing
[21]. Similar results were found in a large sample of uni-
versity students; nightmare frequency correlated signifi-
cantly with low sleep quality scores (e. g., feeling refreshed
after sleep, having headaches in the morning or fitful
sleep) [22].
Furthermore, research has shown that nightmares affect
daytime functioning in terms of reducing general well-
being, increasing anxiety before sleep and after nightmares
and correspond with negative mood and higher stress be-
fore and after sleep [19,21,23–25]. Although there is a cor-
relation between nightmare frequency and waking anxiety
in some studies [19,21,25], other research suggests that
nightmare frequency is independent from general waking
anxiety measures [4,26,27]. One explanation could be that
it is not nightmare frequency per se, but nightmare distress
which influences psychopathology, e. g., anxiety or depres-
sion symptoms [4,25,28,29]. Nightmare distress describes
the suffering and waking effects of having frequent night-
mares that is determined by the way in which people deal
with their dreams and how they influence their thoughts
and behavior [3]. Frequent nightmares and nightmare dis-
tress were found to be strongly associated with neuroti-
cism, irrespective of mental disorders [21,30].
There are only few polysomnographic studies which
evaluated sleep architecture and their results are con-
flicting: Some studies found objective sleep disturbances
[31,32] in frequent nightmare sufferers, others did not
[33,34]. The two positive studies [31,32] observed more
periodic leg movements, increased wakefulness after sleep
onset, relatively less non-REM and slow wave sleep and
a higher relative REM duration in frequent nightmare
sufferers.There are clearly disadvantages when dreams or night-
mares are investigated in laboratory settings: People tend
to dream about the laboratory environment and those
dreams are usually less emotional and shorter than at
home [35–38]. In related disciplines, it has been well rec-
ognized that critical events related to psychopathology –
such as panic attacks – require assessments outside of the
laboratory, when and where those events occur [39].
Therefore, the present study investigates nightmares in
a natural sleep environment and assesses both self-report
and psychophysiological indicators of sleep disturbances.
It was expected that participants with frequent nightmares
experience poorer sleep quality compared to those with




We present results from 34 participants, 17 individuals
with frequent nightmares (DSM criteria [2] with a mini-
mum frequency of at least once a week; mean age 25.18 ±
3.66 yrs; 16 female, 1 male) and 17 healthy control partici-
pants (mean age 24.31 ± 4.69 yrs; 16 female, 1 male). The
groups did not differ in age (t = 0.590, p = 0.563) and
depression scores (t = −0.898, p = 0.377). Exclusion criteria
were the diagnosis of other mental and sleep disorders,
medical conditions or medication with influences on
mood, sleep, or the HPA axis (including antidepressants),
current drug or alcohol abuse and shift work. Telephone
interviews were conducted to screen participants. SCID
[40] questions were applied to assess mental disorders.
Only one participant showed subclinical signs of a prior
episode of major depression and was therefore included in
the study. All other participants did not reveal any signs of
prior or current mental conditions. Furthermore, no
drugs other than contraceptives were taken. Nightmares
were defined as strong negative dreams that awaken the
dreamer and were distinguished from bad dreams without
awakening. All participants signed informed consent and
the study was approved by the local ethics committee.
Sleep recordings
Ambulatory sleep recordings were performed with a V-
Amp amplifier (BrainProducts GmbH, Gilching, Germany).
Raw data was sampled at 500 Hz and processed and filtered
for sleep scoring according to the AASM manual [41]. Ag/
AgCl electrodes were applied and prior to attachment, skin
was pretreated with abrasive paste. Sleep EEG was mea-
sured by ambulatory polysomnographic recording (PSG)
(F4-A1, C4-A1, O2-A1, F3-A2, C3-A2, O1-A2). In addition,
we recorded horizontal and vertical eye movements (EOG),
submental and leg electromyogram (EMG; left and right
anterior tibial muscles), as well as electrocardiogram
(ECG). Periodic leg movements were only measured in
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standard criteria of the AASM [41]. Sleep measures in-
cluded sleep period time (SPT; in minutes), sleep effi-
ciency index (SEI, %), sleep onset latency (in minutes),
REM sleep latency (in minutes), REM sleep density (%),
number of nocturnal awakenings, number of REM pe-
riods, arousal index (AI), amount of wakefulness after
sleep onset (W%), amount of light sleep (N1%), amount of
normal sleep (N2%), amount of slow wave sleep (N3%)
and amount of REM sleep (R%) as well as arousal index in
REM sleep (AIR).
Questionnaires
Subjective sleep quality as well as depressiveness was
assessed by different questionnaires including the
Landecker Inventar zur Erfassung von Schlafstörungen
LISST [42], Schlaffragebogen-A (SF-A) and Schlaffrage
bogen-B (SF-B) [43], Epworth Sleepiness Scale (ESS) [44]
and Beck Depression Inventory (BDI) [45], all German
versions. The SF-B questionnaire measures composite
scores including sleep quality, feeling of being refreshed
in the morning, feeling balanced/relaxed in the evening,
feeling exhausted in the evening and psychosomatic
symptoms in the sleeping period over the last two
weeks. The SF-A yields the same composite scores pro-
spectively for each night the questionnaire was com-
pleted. The LISST results in composite scores to detect
different symptom classes of sleep disorders including
problems with sleep/wake rhythm, insomnia symptoms,
sleep quality, parasomnias and tiredness during the day.
Nightmare frequency was measured on an eight-point
rating scale [46] (‘How often do you experience night-
mares?’ 0 = never, 1 = less than once a month, 2 = about
once a month, 3 = twice or three times a month, 4 =
about once a week, 5 = several times a week and 6 = al-
most every morning). In order to obtain mornings with
dream recall per week, the scale was recoded using the
class means (0→ 0, 1→ 0.125, 2→ 0.25, 3→ 0.625, 4→
1.0, 5→ 3.5, 6→ 6.5).
Procedure
Each participant slept three consecutive nights in their
normal sleep environment at home for polysomnographic
recordings (PSG). After all electrodes were attached, sleep
laboratory staff left and participants went to bed at their
regular times. Participants had to write dream reports on
each nocturnal awakening with dream recall (results will
be reported elsewhere). After awakening in the morning,
the SF-A questionnaire was completed. Again, a mem-
ber of the sleep laboratory detached the electrodes and
controlled recordings. The other questionnaires were
handed out after the last night to ensure that partici-
pants complete them later and not include the three
study nights in their assessments.Hypothesis
We expect that people with frequent nightmares show
worse subjective and objective sleep quality. Regarding
the ambulatory polysomnographic recordings, we antici-
pate that people with frequent nightmares have higher
arousal indices and more awakenings than control par-
ticipants. No other expectations were made because this
is the first study up to date that examines the sleep of
nightmare sufferers in their home environment. On an
exploratory level we want to investigate whether the sleep
architecture differs between participants with frequent
nightmares and healthy controls.
Statistical analysis
Group comparisons were computed by independent t-tests
and repeated measures analysis of variance with nights as
within-subject factor to account for multiple measures
within one participant. The significance level was set as
alpha = 0.05. All group comparisons for the subjective sleep
measures are one-tailed unless otherwise mentioned.
Group comparisons of PSG results were two-tailed ex-
cept AI, AIR and number of awakenings because we
expected those to be higher in NM participants. Effect
sizes are presented as d (d = 0.20: small effect; d = 0.50:




Overall, 96 dreams were reported in 102 nights of ambula-
tory polysomnographic recording. NM participants pro-
vided 49 dream reports, control subjects the remaining 47.
Eleven participants in the NM group reported 13 night-
mares (two participants with two nightmares), five in the
first night, three in the second night and five in the third
night. Also one HC participant reported a nightmare in
the first night.
Retrospective sleep questionnaires
Results of the retrospective sleep questionnaires are pre-
sented in Table 1. NM subjects scored worse on nearly
all subjective sleep measures. Mean nightmare frequency
in the NM group was ‘several times a week’ whereas HC
participants reported to have nightmares between ‘less
than once a month’ and ‘once a month’ (HC: 0.27 ± 0.30;
NM: 3.08 ± 2.13; t = −5.040, p < 0.001, d = 1.91). Sleep
quality was assessed by two questionnaires separately.
Both measures revealed lower values in NM subjects
(LISST: t = −2.864, p = 0.004, d = 1.03; SF-B: t = −3.903,
p < 0.001, d = 0.92). Regarding other sleep complaints,
NM participants scored significantly higher in insomnia
problems (t = −3.697, p < 0.001, d = 1.33) as well as para-
somnia complaints (t = −3.903, p < 0.001, d = 1.40) and
marginally higher in problems with sleep/wake pattern
(t = −1.615, p = 0.059, d = 0.58). No group differences were
Table 1 Sleep questionnaire results comparing frequent nightmare sufferers (NM) with healthy controls (HC)
Scale (questionnaire) NM HC NM vs. HC Effect size
t p d
Daytime sleepiness (ESS) 9.53 ± 3.27 7.44 ± 2.68 −1.596 0.03* 0.70
Sleep quality (LISST) 21.04 ± 5.34 15.13 ± 6.10 −2.864 0.004* 1.03
Apnea symptoms (LISST) 5.40 ± 2.59 4.33 ± 0.82 −1.528 0.145 0.57
RLS symptoms (LISST) 7.67 ± 2.06 8.06 ± 3.49 0.381 0.706 0.13
Problems with sleep/wake pattern (LISST) 19.20 ± 6.33 15.69 ± 5.78 −1.615 0.059* 0.58
Insomnia symptoms (LISST) 17.87 ± 4.93 11.75 ± 4.28 −3.697 < 0.001* 1.33
Tiredness during the day (LISST) 15.47 ± 6.63 10.75 ± 4.17 −2.353 0.013* 0.86
Parasomnias (LISST) 18.68 ± 6.60 10.69 ± 4.70 −3.903 < 0.001* 1.40
Sleep quality (SF-B) 3.39 ± 0.59 3.88 ± 0.47 2.603 0.007* 0.92
Feeling of being refreshed (SF-B) 2.59 ± 0.77 3.09 ± 0.83 1.713 0.049* 0.62
Feeling balanced/relaxed in the evening (SF-B) 3.02 ± 0.59 3.69 ± 0.68 2.911 0.004* 1.05
Feeling exhausted in the evening (SF-B) 3.84 ± 0.59 3.94 ± 0.68 0.406 0.344* 0.16
Psychosomatic symptoms while sleeping (SF-B) 1.90 ± 0.73 1.66 ± 0.45 −1.112 0.139* 0.40
ESS: Epworth Sleepiness Scale [41], LISST: Landecker Inventar zur Erfassung von Schlafstörungen [39], SF-B: Schlaffragebogen-B [40].
Results are presented as mean ± standard deviation; effect sizes as d.
*One-tailed t-test.
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two-tailed), restless legs symptoms (t = 0.381, p = 0.706,
d = 0.13; two-tailed) and psychosomatic symptoms in
the sleeping period (t = −1.112, p = 0.139, d = 0.40).
Concerning daytime dysfunction, nightmare partici-
pants revealed significantly worse scores in daytime
sleepiness (t = −1.596, p = 0.03, d = 0.70), daytime tired-
ness (t = −2.353, p = 0.013, d = 0.86), feeling of being
refreshed after sleep (t = 1.713, p = 0.049, d = 0.62) and
feeling balanced/relaxed in the evening (t = 2.911, t = 0.004,
d = 1.05). No difference was found for feeling exhausted in
the evening (t = 0.406, p = 0.344, d = 0.40).
Subjective sleep measures in the study nights
Two participants provided not enough valid answers in
the sleep questionnaire regarding subjective sleep quality
of each night of the study so results are presented for 32
subjects (see Table 2). Analysis revealed that sleep qual-
ity increased over the three nights (F(2,60) = 20.706, p <Table 2 Self reported sleep measures of all study nights colle
(NM) and healthy controls (HC)
Measure Night 1
NM HC
Sleep quality 2.63 ± 0.64 3.03 ± 0.81
Feeling of being refreshed after sleep 2.49 ± 0.59 3.13 ± 0.83
Feeling balanced/relaxed in the evening 3.19 ± 0.70 3.63 ± 0.65
Feeling exhausted in the evening 2.98 ± 0.72 2.81 ± 0.78
Psychosomatic symptoms while sleeping 1.79 ± 0.52 1.76 ± 0.49
SF-A: Schlaffragebogen-A [40].
Results are presented as mean ± standard deviation.0.001, ηp
2 = 0.408) in both groups. A significant group
effect (F(1,30) = 2.599, p = 0.04, ηp
2 = 0.079) indicated
that NM participants generally scored worse in sleep
quality. NM subjects felt less refreshed after sleep indi-
cated by a significant group effect (F(1,30) = 7.678, p =
0.005, ηp
2 = 0.204). Moreover, the NM group felt less
balanced in the evening (F(1,30) = 6.330, p = 0.009, ηp
2 =
0.174). No group or main effect was found for feeling
exhausted in the evening (F(1,30) = 0.242, p = 0.313;
F(2,60) = 0.476, p = 0.312, resp.). Psychosomatic symp-
toms in the sleeping period generally decreased from N1
to N3, indicated by a significant main effect of Night
(F(2,60) = 3.310, p = 0.044, ηp
2 = 0.099); there was no dif-
ference between the groups (F(1,30) = 0.002, p = 0.485).
Ambulatory polysomnography
Results from the ambulatory polysomnographic recordings
(see Table 3) revealed no difference in SPT between the
groups (F(1,32) = 1.002, p = 0.324). SEI generally increasedcted by SF-A questionnaire for nightmare sufferers
Night 2 Night 3
NM HC NM HC
3.44 ± 0.58 3.49 ± 0.69 3.33 ± 0.60 3.75 ± 0.51
2.85 ± 0.72 3.20 ± 0.84 2.82 ± 0.61 3.40 ± 0.78
3.36 ± 0.78 3.73 ± 0.57 3.29 ± 0.58 3.93 ± 0.60
2.94 ± 0.56 2.94 ± 68 3.06 ± 0.54 2.91 ± 0.74
1.67 ± 0.65 1.68 ± 0.47 1.49 ± 0.47 1.60 ± 0.43
Table 3 Sleep parameters of the three study nights for nightmare sufferers (NM) and healthy controls (HC)
Variable Night 1 Night 2 Night 3
NM HC NM HC NM HC
Sleep period time (min) 453.73 ± 59.57 453.35 ± 68.57 454.70 ± 48.86 462.55 ± 72.73 430.11 ± 42.16 464.35 ± 54.12
Sleep efficiency (%) 83.51 ± 9.19 84.99 ± 7.06 90.99 ± 3.23 88.21 ± 7.08 90.28 ± 3.82 90.47 ± 4.25
Sleep onset latency (min) 18.76 ± 13.51 22.50 ± 23.87 15.26 ± 9.55 18.85 ± 16.90 16.97 ± 13.25 16.82 ± 11.46
REM latency (min) 105.47 ± 50.44 104.32 ± 48.36 78.79 ± 37.48 94.50 ± 40.95 81.47 ± 31.87 99.88 ± 43.70
REM density 20.78 ± 6.45 18.86 ± 5.44 21.06 ± 5.07 20.52 ± 5.71 21.11 ± 6.90 19.50 ± 6.41
Number of awakenings 26.94 ± 10.07 23.82 ± 8.79 24.82 ± 9.36 24.59 ± 10.89 22.41 ± 6.22 26.35 ± 9.17
Number of REM periods 3,06 ± 0,899 2,94 ± 0,966 3,82 ± 0,636 3,53 ± 1,419 3,29 ± 1,213 3,41 ± 1,004
Arousal Index 10.68 ± 3.64 8.78 ± 1.86 10.38 ± 3.35 9.09 ± 2.04 9.33 ± 2.62 9.75 ± 2.06
Awake% 11.45 ± 7.58 9.54 ± 5.33 5.67 ± 2.88 6.48 ± 5.05 5.76 ± 2.72 5.82 ± 3.59
Stage N1% 9.22 ± 3.03 8.03 ± 3.91 8.33 ± 3.92 8.20 ± 3.96 8.39 ± 3.93 9.00 ± 2.94
Stage N2% 42.74 ± 5.92 46.41 ± 6.18 45.25 ± 7.62 46.50 ± 9.01 45.01 ± 6.77 47.35 ± 7.11
Stage N3% 22.48 ± 9.24 20.77 ± 11.04 23.96 ± 9.30 20.95 ± 9.68 24.75 ± 7.87 21.57 ± 9.52
Stage REM% 13.92 ± 3.60 14.70 ± 3.85 16.75 ± 3.84 15.41 ± 4.21 16.05 ± 3.68 16.20 ± 3.70
Arousal Index (REM only) 9.85 ± 5.05 7.57 ± 3.47 9.66 ± 4.77 9.20 ± 4.43 10.37 ± 5.24 8.15 ± 4.23
Periodic leg movements 3.00 ± 6.36 1.95 ± 3.81
Periodic leg movements with arousal 0.18 ± .59 0.23 ± .50
Results are presented as mean ± standard deviation.
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2 =
0.286) but did not differ between groups (F(1,32) = 0.062,
p = 0.805). In all participants the amount of time awake
decreased indicated by a significant Night effect for W%
(F(2,64) = 13.595, p < 0.001, ηp
2 = 0.298) while REM% in-
creased (F(2,64) = 3.351, p = 0.041, ηp
2 = 0.095). No group
differences could be found for both measures (F(1,32) =
0.088, p = 0.768; F(1,32) = 0.021, p = 0.884). There was a
significant Night effect for the number of REM periods
(F(2,64) = 5.557, p = 0.006, ηp
2 = 0.148). Group compari-
sons for the amount of awakenings, AI and AIR were
not significant (F(1,32) = 0.005, p = 0.942; F(1,32) = 1.389,
p = 0.247; F(1,32) = 1.680, p = 0.102, resp.). No group dif-
ferences were found for sleep latency (F(1,32) = 0.286, p =
0.597), REM latency (F(1,32) = 1.068, p = 0.309), REM
density (F(1,32) = 0.555, p = 0.462), number of REM pe-
riods (F(1,32) = 0.125, p = 0.723), stage N1% (F(1,32) =
0.042, p = 0.838), stage N2% (F(1,32) = 1.226, p = 0.276),
stage N3% (F(1,32) = 0.742, p = 0.395) ) and the amount of
periodic leg movements with (t = −1.335, p = 0.201) or
without arousals (t = −1.228, p = 0.237).
We found a marginally significant Group ×Night inter-
action for the number of nocturnal awakenings (F(2,64) =
2.894, p = 0.063, ηp
2 = 0.083) with decreasing awakenings
in the NM group and increasing awakenings in the HC
group. Moreover, there was a significant Group ×Night
interaction for AI (F(2,64 = 4.023, p = 0.023, ηp
2 = 0.112)
represented by decreasing AI in the NM group and in-
creasing AI in the HC participants. No other interactions
were found.Because no group differences could be found in sleep
architecture over all three nights, we further analyzed
the data by comparing only those nights where night-
mares occurred in the NM group. For comparison, nights
of the HC participants were selected by matching age,
night and time of nightmare with those dreams of the NM
group. Results are presented in Table 4. Again, no signifi-
cant group differences could be found.
We further looked at the distinct sleep cycles to po-
tentially find differences in sleep microstructure. First,
the number of REM periods in each night will be pre-
sented for NM and HC participants. Night 1, NM sub-
jects: 5 NMs with two REM periods, 7 NMs with three
REM periods, 4 NMs with four REM periods and 1 NMs
with five REM periods. Night 1, HC subjects: 1 HCs with
one REM period, 4 HCs with two REM periods, 8 HCs
with three REM periods, 3 HCs with four REM periods
and 1 HCs with five REM periods. Night 2, NM subjects:
5 NMs with three REM periods, 10 NMs with four REM
periods and 2 NMs with five REM periods. Night 2, HC
subjects: 1 HCs with one REM period, 3 HCs with two
REM periods, 4 HCs with three REM periods, 6 HCs
with four REM periods, 2 HCs with five REM periods
and 1 HCs with seven REM periods. Night 3, NM sub-
jects: 5 NMs with two REM periods, 6 NMs with three
REM periods, 3 NMs with four REM periods, 2 NMs
with five REM periods and 1 NMs with six REM periods
Night 3, HC subjects: 3 HCs with two REM periods, 7
HCs with three REM periods, 4 HCs with four REM pe-
riods and 3 HCs with five REM periods.
Table 4 Sleep parameters of nights with nightmares in frequent nightmare sufferers (NM) compared with matched
nights of healthy controls (HC)
Variable NM HC NM vs. HC Effect size
n = 11 n = 11 t p d
Sleep period time (min) 444.63 ± 58.20 461.36 ± 61.98 −0.652 0.522 0.28
Sleep efficiency (%) 84.73 ± 9.65 85.65 ± 6.64 −0.262 0.796 0.11
Sleep onset latency (min) 20.77 ± 13.55 15.364 ± 10.02 1.064 0.300 0.45
REM latency (min) 86.54 ± 42.78 95.04 ± 39.64 −0.483 0.634 0.21
REM density 21.68 ± 8.10 22.80 ± 7.00 −0.348 0.731 0.15
Number of awakenings 28.36 ± 11.38 28.73 ± 8.90 −0.083 0.467* 0.04
Number of REM periods 3.45 ± 1.29 3.27 ± 0.64 0.417 0.683 0.18
Arousal Index 10.63 ± 3.19 9.46 ± 1.21 1.130 0.140* 0.48
Awake% 11.02 ± 9.06 10.95 ± 6.07 0.022 0.983 0.01
Stage N1% 10.14 ± 3.19 8.24 ± 3.36 1.353 0.191 0.58
Stage N2% 44.89 ± 6.61 44.23 ± 7.02 0.227 0.823 0.10
Stage N3% 19.83 ± 6.86 21.22 ± 8.51 −0.423 0.677 0.18
Stage REM% 14.08 ± 3.85 15.32 ± 3.53 −0.786 0.441 0.34
Arousal index (REM only) 10.73 ± 5.15 12.09 ± 8.38 0.519 0.305* 0.22
Periodic leg movements 1.78 ± 5.91 1.18 ± 3.94 0.278 0.784 0.12
Results are presented as mean ± standard deviation.
*One-tailed t-test.
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the first, second, third and fourth REM/NREM cycles
were conducted. Results are presented in Table 5.
Again, no group differences could be found for cycle
length (F(1,32) = 0.553, p = 0.463; F(1,30) = 0.478, p = 0.494;
F(1,15) = 0.055, p = 0.818; F(1,5) = 0.033, p = 0.863), dur-
ation of REM in the respective cycle (F(1,32) = 0.006, p =
0.941; F(1,32) = 0.301, p = 0.587; F(1,30) = 0.202, p = 0.657;
F(1,15) = 1.104, p = 0.310) or REM density (F(1,32) = 0.351,
p = 0.558; F(1,32) = 0.034, p = 0.855; F(1,30) = 0.064, p =Table 5 REM sleep parameters by different sleep cycles and n
controls (HC)
Cycle Variable Night 1 Ni
NM HC NM
1 Cycle length 103.47 ± 32.06 104.70 ± 19.61 94
REM duration 13.08 ± 13.85 13.94 ± 7.96 13
REM density 15.13 ± 6.76 13.57 ± 6.65 14
2 Cycle length 106.64 ± 26.22 96.30 ± 22.13 93
REM duration 24.35 ± 15.42 20.94 ± 10.55 15
REM density 20.23 ± 8.72 18.90 ± 8.33 17
3 Cycle length 92.49 ± 22.09 88.00 ± 37.16 80
REM duration 20.58 ± 11.60 21.53 ± 8.01 23
REM density 19.77 ± 9.57 21.65 ± 7.76 21
4 Cycle length 83.00 ± 10.10 79.83 ± 13.96 77
REM duration 28.00 ± 14.77 32.18 ± 8.92 22
REM density 21.15 ± 8.95 23.26 ± 9.01 21
Results are presented as mean ± standard deviation; cycle length and REM duration0.802; F(1,15) = 1.455, p = 0.246). No Night effects or
Group × Night interactions could be found.
Discussion
Among the few studies designed to examine the effects
of nightmares in multiple modalities, this is the first to
do so under ecologically valid conditions. Our findings
support the notion that sleep in people with frequent
nightmares is subjectively disturbed compared to healthy
controls [20,26,31]. Individuals who suffer from nightmaresights for frequent nightmare sufferers (NM) and healthy
ght 2 Night 3
HC NM HC
.05 ± 18.67 110.08 ± 51.54 100.26 ± 21.10 97.94 ± 18.08
.94 ± 10.98 13.52 ± 10.98 14.02 ± 6.91 14.11 ± 9.48
.76 ± 7.20 13.73 ± 8.53 13.57 ± 6.30 13.24 ± 6.30
.05 ± 27.12 90.39 ± 25.86 99.67 ± 12.02 101.36 ± 16.59
.29 ± 9.25 21.76 ± 10.73 25.44 ± 8.78 25.58 ± 9.70
.35 ± 9.53 19.56 ± 9.60 21.48 ± 10.6 19.21 ± 10.49
.72 ± 22.00 83.75 ± 21.22 80.77 ± 15.93 77.56 ± 17.62
.35 ± 10.27 18.96 ± 15.31 24.26 ± 13.71 23.93 ± 12.21
.22 ± 8.60 21.25 ± 12.29 18.83 ± 6.44 18.37 ± 5.92
.37 ± 9.31 84.16 ± 8.37 72.62 ± 8.26 66.16 ± 25.15
.61 ± 15.64 27.06 ± 11.14 21.11 ± 10.25 23.12 ± 12.69
.52 ± 6.59 24.62 ± 8.94 22.46 ± 13.31 30.82 ± 9.35
are presented in minutes.
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insomnia complaints) as well as daytime dysfunction like
tiredness and mood problems. However, these complaints
could not be confirmed by ambulatory polysomnographic
recordings. We found no differences between both groups
regarding the sleep parameters when (a) total sleep over all
three night was considered, (b) sleep cycles were analyzed
regarding cycle length, amount of REM sleep and REM
density and (c) only the nights with nightmares in the NM
group were compared with corresponding nights of control
participants (without nightmares).
Although no differences in sleep patterns could be
found when only nights with nightmares and compar-
able nights of control participants with neutral dreams
were analyzed, some results have to be discussed more
detailed. Highest effect sizes (small-medium to medium)
were found for sleep onset latency (NM longer), arousal
index (NM higher), percentage of stage N1 (NM more)
and percentage of stage REM (NM less). All differences
point in the expected direction which suggests that
nightmare sufferers may potentially differ in sleep archi-
tecture. Overall, we found almost exclusively high effects
on self reported sleep quality with significant differences
between both groups and some small to medium effects
for objective sleep quality that were not significantly dif-
ferent. Nightmares seem to influence subjective sleep
quality more severely than physiological sleep pattern.
Future ambulatory studies should include more NM
subjects to unveil possible sleep pattern differences.
Our finding of comparable sleep architecture between
nightmare sufferers and healthy controls is contrary to
two prior studies showing that there are differences in
sleep patterns [31,32]. It is possible that nightmare suf-
ferers are more sensitive to changes in their usual sleep
practice and therefore, exhibit worse and more aroused
sleep in laboratory settings. This assumption is supported
by a recent study which has shown an enhanced first-
night effect in NM subjects [47]. The first-night effect
refers to the fact that sleep differs between the first and
second night in sleep laboratory settings. The authors
underline that their finding emerged mainly due to the
large baseline difference: NM subjects slept much worse
during the first night [47]. An advantage of the present
investigation is the ambulatory setting for polysomno-
graphic recordings. Applying this procedure, we found no
differences in the sleep architecture between frequent
nightmare sufferers and healthy controls. Moreover, prior
research suggests that nightmares are less frequent in
laboratory settings [48]. It is possible that differences in
sleep architecture in the laboratory studies are due to the
unnatural sleep environment [49]. More ambulatory stud-
ies are needed to further clarify this assumption.
Another explanation for the contrary findings could be
that all studies which investigated differences in sleeparchitecture had more or less different designs, proce-
dures and ways of analyzing the data. Both studies that
found differences analyzed sleep parameters of the sec-
ond of two nights only, the first night served as an adap-
tation night [31,32]. Those two studies that found no
differences [33,34] investigated the effects of REM sleep
deprivation (night one and three were analyzed; in the
second night, participants were deprived of REM sleep).
Therefore, the results should be treated with caution be-
cause sleep architecture is affected by REM deprivation
and findings from the first night could be biased by first-
night effect [47]. These differences in the designs of pre-
vious polysomnographic nightmare studies could explain
the different findings and limit general conclusions.
Furthermore, characteristics of the control participants
could also influence the results. Our controls scored con-
sistently higher on almost all measures of sleep quality
and there were no signs of either mental or sleep disor-
ders. They were included if nightmares occurred less than
once a month. Two studies had the same criteria [33,34],
one included controls with less than two nightmares/bad
dreams during the last year [31] and the other one did not
specify this issue [32]. However, other studies may have
included different controls, none of the previous investiga-
tions [31–34] found differences in terms of sleep efficiency
for example.
It is possible that the results of previous studies were
influenced by different characteristics of nightmare suf-
ferers. In one investigation which found differences in
sleep patterns between NM and control participants
[32], depression and anxiety measures were not able to
distinguish between both groups. The second study that
found differences [31] included NM participants with
higher scores for self reported symptoms of depression
and anxiety than control subjects. However, in those
two studies where no differences in sleep architecture
were observed [33,34], nightmare sufferers also reported
higher scores in anxiety and depression symptoms. In
the present study groups did not differ in terms of
depression symptoms. Based on these inconclusive
findings, it can not be assumed that variations in the
characteristics of the nightmare sufferers leaded to the
different results.
We found that the number of REM periods and the
amount of REM sleep increased over the nights, while the
time awake after sleep onset decreased. The other sleep
stages did not differ in the course of the investigation. It
seems that with decreasing time awake, the amount of
REM sleep increased together with the number of REM
periods. This could be explained by REM rebound. Maybe
our participants did not get their adequate amount of
REM sleep in the first night which leads to increased
REM pressure and therefore, more REM sleep and periods
in the following night(s). One could also think about the
Paul et al. Borderline Personality Disorder and Emotion Dysregulation  (2015) 2:3 Page 8 of 9first-night effect to explain the pattern but our data does
not allow final conclusions.
Expectation anxiety in nightmare sufferers could also ex-
plain differences between subjective and objective sleep
quality. The fear of falling asleep and having severe night-
mares affect subjective sleep quality but may not influence
physiological sleep patterns. Future studies should evaluate
the magnitude of expectation anxiety before each investi-
gated night. Previous research also revealed a connection
between subjective stress and nightmare distress as well as
psychopathology and nightmare distress [28]. As we did
not ask questions regarding nightmare distress, it would be
interesting to conduct ambulatory studies differentiating
between nightmare frequency and nightmare distress.
Some limitations of our findings have to be addressed.
Our participants had to write dream reports each time
they woke up in the night and remembered a dream.
This leads to artificially prolonged waking periods and
may mask differences in comparison to undisturbed sleep
patterns, e. g. sleep efficiency. It is possible for example,
that people without frequent nightmares fall asleep much
faster after awakening from a dream than nightmare
sufferers do. Therefore, future studies should include
control groups or nights in which no dream reports
have to be provided.
Even a prior study [22] reported that the relationship
between nightmare frequency and poor sleep quality was
still significant after controlling neuroticism scores, it
would be very interesting to study whether neuroticism
as a trait (not measured in the present study) is related
to subjective and objective sleep parameters.
Conclusions
Our results suggest that nightmare disorder is independ-
ent from objective sleep disturbances but causes waking
distress, negative mood, non-restorative sleep and tired-
ness during the day. Therefore, nightmares should be
seen as a distinct sleep disorder with specific symptoms
that needs specific treatment. Future studies should con-
centrate on ambulatory polysomnographic recordings to
investigate sleep in natural environments to detect sleep
and dream complaints in people with nightmares. Fur-
thermore, the difference between nightmare distress and
nightmare frequency should be regarded which may lead
to new insights concerning objective sleep measures.
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